Alignment Healthcare, Inc. (ALHC)
NASDAQ: ALHC · Real-Time Price · USD
13.65
-1.68 (-10.93%)
Jun 1, 2026, 2:20 PM EDT - Market open
Alignment Healthcare Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 19.79 | -0.98 | -128.07 | -148.17 | -149.64 | -195.29 |
Depreciation & Amortization | 30.72 | 30.48 | 27.06 | 21.67 | 17.49 | 16.03 |
Stock-Based Compensation | 58.91 | 62.08 | 71.13 | 66.84 | 81.72 | 110.6 |
Other Adjustments | 2.99 | 2.83 | 3.76 | -1.54 | 10.56 | 9.29 |
Change in Receivables | -64.42 | -100.11 | -34.28 | -26.95 | -34.38 | -17.61 |
Changes in Accounts Payable | 5.29 | 10.36 | -1.46 | -6.35 | 13.74 | 0.44 |
Changes in Accrued Expenses | 1.93 | 9.08 | 5.82 | 6.57 | 3.61 | -1.24 |
Changes in Unearned Revenue | -0.03 | - | - | - | - | - |
Changes in Other Operating Activities | 196.69 | 126.17 | 90.81 | 28.75 | 11.47 | -1 |
Operating Cash Flow | 296.11 | 139.93 | 34.77 | -59.19 | -45.43 | -78.78 |
Operating Cash Flow Growth | 475.52% | 302.44% | - | - | - | - |
Capital Expenditures | -25.89 | -26.78 | -41.42 | -36 | -23.77 | -18.36 |
Sale of Property, Plant & Equipment | -0.04 | - | 0.08 | 0.01 | - | - |
Purchases of Investments | -58.33 | -65.63 | -82.2 | -379.06 | -2.83 | -2.48 |
Proceeds from Sale of Investments | 72.15 | 76.3 | 162.8 | 267.79 | 2.43 | 1.43 |
Payments for Business Acquisitions | - | - | - | - | -4.04 | -1.41 |
Proceeds from Business Divestments | 0.53 | 1.07 | - | - | - | - |
Investing Cash Flow | -10.93 | -14.97 | 39.19 | -147.26 | -28.22 | -20.82 |
Long-Term Debt Issued | - | - | 380 | - | 165 | - |
Long-Term Debt Repaid | - | - | -215 | - | -143.18 | - |
Net Long-Term Debt Issued (Repaid) | - | - | 165 | - | 21.82 | - |
Issuance of Common Stock | 20.03 | 18.07 | 0.16 | - | - | 361.59 |
Repurchase of Common Stock | - | - | - | - | - | -1.47 |
Net Common Stock Issued (Repurchased) | 20.03 | 18.07 | 0.16 | - | - | 360.12 |
Other Financing Activities | -1.66 | -0.03 | -9.13 | 0.11 | -5.23 | 0.02 |
Financing Cash Flow | 18.38 | 18.04 | 156.03 | 0.11 | 16.59 | 360.13 |
Net Cash Flow | 259.43 | 142.99 | 229.99 | -206.35 | -57.05 | 260.54 |
Free Cash Flow | 270.22 | 113.15 | -6.65 | -95.18 | -69.2 | -97.14 |
Free Cash Flow Growth | 138.82% | - | - | - | - | - |
FCF Margin | 6.35% | 2.87% | -0.25% | -5.22% | -4.83% | -8.32% |
Free Cash Flow Per Share | 1.30 | 0.57 | -0.03 | -0.51 | -0.38 | -0.56 |
Levered Free Cash Flow | 228.51 | 148.59 | 117.78 | -133.37 | -105.19 | -199.42 |
Unlevered Free Cash Flow | 244.31 | 164.38 | -20.76 | -113.15 | -106.4 | -182.21 |